Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.
about
Analgesic effect of Coptis chinensis rhizomes (Coptidis Rhizoma) extract on rat model of irritable bowel syndromeDigestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome: Validation of Symptom Frequency Questionnaire.Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales.The Intestinal Gas Questionnaire: development of a new instrument for measuring gas-related symptoms and their impact on daily life.Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis.Understanding gastrointestinal distress: a framework for clinical practice.Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.Role of neuronal nitric oxide synthase in colonic distension-induced hyperalgesia in distal colon of neonatal maternal separated male ratsDevelopment of determination of four analytes of Zhi-Shao-San decoction using LC-MS/MS and its application to comparative pharmacokinetics in normal and irritable bowel syndrome rat plasma.Systematic review: instruments to assess abdominal pain in irritable bowel syndrome.Clinically Diagnosed Acute Diverticulitis in Outpatients: Misdiagnosis in Patients with Irritable Bowel Syndrome.Linaclotide: promising IBS-C efficacy in an era of provisional study endpoints.Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome.Irritable bowel syndrome subtype screening characteristics: constipation subtype patient profiles explored.
P2860
Q24631963-6A07D8D9-8CDC-4FD3-8351-0FE0F9C94888Q33462226-8E90A05E-4E1C-4D32-9B4C-42824B1DAD7BQ33462837-259A1D5E-BF29-444C-8781-F8AFE1F634A2Q33464699-0AA23A9E-495C-4610-8244-86A915FC5959Q33465076-41EC7DB3-9E78-49B9-BC81-C7D3772BBB21Q34764170-036BE452-DB3D-4DDD-BE02-DF7B53125340Q34827191-CBA51913-A7A4-4593-AD34-BF1A8D13E78EQ35053554-7E860D3A-7A8A-43A6-8925-7DAF508998DAQ35136319-ACB39CF9-97C6-451B-AB22-3D789BBAD26DQ38569948-DE4334E7-9455-4E9B-8A9A-67F9F72A102CQ40964197-8E85B279-8D26-41D3-8A04-BFE8E0EF469CQ42408269-3D355144-8C06-4E64-941A-DBD864C41BADQ43366227-0D45B1FB-9004-4ADD-9B4A-62BA4D882924Q54960762-F9B0718A-7451-4D6F-8747-3633229468D9
P2860
Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characterizing abdominal pain ...... urement and clinical practice.
@ast
Characterizing abdominal pain ...... urement and clinical practice.
@en
type
label
Characterizing abdominal pain ...... urement and clinical practice.
@ast
Characterizing abdominal pain ...... urement and clinical practice.
@en
prefLabel
Characterizing abdominal pain ...... urement and clinical practice.
@ast
Characterizing abdominal pain ...... urement and clinical practice.
@en
P2093
P2860
P1476
Characterizing abdominal pain ...... urement and clinical practice.
@en
P2093
B M R Spiegel
E Esrailian
K Tillisch
L A Harris
P2860
P304
P356
10.1111/J.1365-2036.2010.04443.X
P407
P577
2010-08-30T00:00:00Z